Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
MAP Pharmaceuticals, Inc.
(NQ:
MAPP
)
24.98
USD
UNCHANGED
Last Price
/ Updated:
8:10 PM EST, Mar 1, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about MAP Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
Next >
65.4% Return Seen to Date on SmarTrend MAP Pharmaceuticals Call (MAPP)
March 04, 2013
from
Comtex SmarTrend® News Briefs
UPDATE: Wedbush Downgrades MAP Pharmaceuticals to Neutral, Reiterates $25 PT on Likely Acquisition
March 01, 2013
In a report published Friday, Wedbush downgraded its rating on MAP Pharmaceuticals (NASDAQ: MAPP ) from Outperform to Neutral, and reiterated its $25.00 price target. Wedbush noted, “Allergan...
Read More
category
Benzinga
,
Downgrades
,
Wedbush
, and 3 more.
from
Latest Articles from Benzinga.com
Wedbush Downgrades MAP Pharmaceuticals (MAPP) to Neutral
March 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8147201 for the full story.
Read More
from
StreetInsider.com News Articles
Short Interest Jumps 38.3% For MAPP
February 28, 2013
The most recent short interest data has been released by the NASDAQ for the 02/15/2013 settlement date, which shows a 1,762,626 share increase in total short interest for Map Pharmaceuticals...
Read More
category
Stocks
from
Market News Video
Uptrend Call Working As MAP Pharmaceuticals Stock Rises 65.1% (MAPP)
February 23, 2013
from
Comtex SmarTrend® News Briefs
Uptrend Call Working As MAP Pharmaceuticals Stock Rises 64.9% (MAPP)
February 15, 2013
from
Comtex SmarTrend® News Briefs
MAP Pharmaceuticals: The Winning Streak Continues (MAPP)
February 11, 2013
from
Comtex SmarTrend® News Briefs
MAP Pharmaceuticals Has Returned 64.8% Since SmarTrend Recommendation (MAPP)
February 07, 2013
from
Comtex SmarTrend® News Briefs
Examining Block Trading Activity & Unusual Options Volume for MAP Pharmaceuticals
February 07, 2013
NEW YORK (AVAFIN) -- A total of 17 block trades were executed today, typically ...
Read More
from
AVAFIN
Watch for Continued Gains in Shares of MAP Pharmaceuticals (MAPP)
February 06, 2013
from
Comtex SmarTrend® News Briefs
MAP Pharmaceuticals: The Winning Streak Continues (MAPP)
February 04, 2013
from
Comtex SmarTrend® News Briefs
Ladenburg Thalmann Downgrades MAP Pharmaceuticals (MAPP) to Neutral
February 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8051053 for the full story.
Read More
from
StreetInsider.com News Articles
MAP Pharmaceuticals Has Returned 64.1% Since SmarTrend Recommendation (MAPP)
January 31, 2013
from
Comtex SmarTrend® News Briefs
Map Pharmaceuticals Spikes Higher
January 30, 2013
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Read More
category
Benzinga
,
News
,
MAPP
from
Latest Articles from Benzinga.com
Deutsche Bank Downgrades MAP Pharmaceuticals (MAPP) to Hold; Doesn't Expect Other Bids
January 28, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8034601 for the full story.
Read More
from
StreetInsider.com News Articles
UPDATE: Deutsche Bank Downgrades MAP Pharmaceuticals to Hold Following Acquisition Bid
January 28, 2013
Deutsche Bank downgraded MAP Pharmaceuticals (NASDAQ: MAPP ) from Buy to Hold and raised the price target from $20.00 to $25.00. Deutsche Bank noted, "We are lowering our investment rating on MAP...
Read More
category
Deutsche Bank
,
Pre/Market Outlook
,
Benzinga
, and 4 more.
from
Latest Articles from Benzinga.com
Downgrade Alert for MAP Pharmaceuticals (MAPP)
January 28, 2013
from
Comtex SmarTrend® News Briefs
Biotech Movers: Arena Gets Warned, MAP Gets an Offer
January 28, 2013
Read More
category
NASDAQ:SRPT
,
Hot Stocks
,
NASDAQ:MAPP
, and 3 more.
from
InvestorPlace - Latest Headlines
Mergers and Acquisitions Remain Key in Big Pharma's 2013 Playbook
January 28, 2013
SUGAR LAND--January 28, 2013--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--In the absence of the avalanche of mega-industry mergers and acquisitions (M&A) seen in...
Read More
from
IIR Industry News Alerts
Updated SmallCapPower Weekly Gainers/Losers: Top Gainer Cline Mining Corp. (TSX: CMK) +200%
January 27, 2013
from
ACCESSWIRE
Watch for Continued Gains in Shares of MAP Pharmaceuticals (MAPP)
January 24, 2013
from
Comtex SmarTrend® News Briefs
UPDATE: Canaccord Genuity Downgrades MAP Pharmaceuticals to Hold Following Takeover
January 24, 2013
Canaccord Genuity downgraded MAP Pharmaceuticals (NASDAQ: MAPP ) from Buy to Hold and raised the price target from $23.00 to $25.00. Canaccord Genuity commented, "Post yesterday's announcement of...
Read More
category
Canaccord Genuity
,
Benzinga
,
US56509R1086
, and 5 more.
from
Latest Articles from Benzinga.com
Canaccord Genuity Downgrades MAP Pharmaceuticals (MAPP) to Hold
January 24, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8028443 for the full story.
Read More
from
StreetInsider.com News Articles
Downgrade Alert for MAP Pharmaceuticals (MAPP)
January 24, 2013
from
Comtex SmarTrend® News Briefs
Leerink Swann Downgrades MAP Pharmaceuticals (MAPP) to Market Perform
January 24, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8027851 for the full story.
Read More
from
StreetInsider.com News Articles
Benzinga's M&A Chatter for Wednesday January 23, 2013
January 23, 2013
The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday January 23, 2013: Hearing Chatter of Private Equity Interest in JC Penney The Rumor:Shares of JC Penney...
Read More
category
Benzinga
,
Movers
,
Global
, and 20 more.
from
Latest Articles from Benzinga.com
Allergan To Pay $958 Million For MAP
January 23, 2013
MAP Pharmaceuticals Inc. (Nasdaq: MAPP) will be acquired by Allergan INc. (NYSE: AGN) for a premium of approximately $958 million in cash. Shares of MAP leaped $9.12 to $24.70 while Allergan stock lost...
Read More
from
MarketMinute.com Stock News
Unusual 11 Mid-Day Movers 01/23: (MAPP) (CREE) (THLD) Higher; (STRI) (SMCI) (COH) Lower
January 23, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8026169 for the full story.
Read More
from
StreetInsider.com News Articles
Mid-Day Market Update: AMD Remains Up, Cyberonics Takes a Beating
January 23, 2013
Mid-way through trading Wednesday, the Dow traded up 0.37 percent to 13,763.13 while the NASDAQ rose 0.37 percent to 3,149.63. The S&P fell however, decreasing 0.04 percent to 1,491.93. Top Headline...
Read More
category
Earnings
,
Benzinga
,
Movers
, and 33 more.
from
Latest Articles from Benzinga.com
MAP Pharmaceuticals Rising Today on Above-Average Volume (MAPP)
January 23, 2013
from
Comtex SmarTrend® News Briefs
< Previous
1
2
3
4
5
6
7
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here